3 Biotech Stocks Reacting to Guggenheim ‘Buy’ Ratings – Schaeffers Research (blog)


Schaeffers Research (blog)
3 Biotech Stocks Reacting to Guggenheim ‘Buy’ Ratings
Schaeffers Research (blog)
Options traders have been quick to respond to BIIB stock, with 37,213 contracts exchanged — almost seven times the average intraday rate, and a new 12-month high. The weekly 10/27 320-strike call is most active, and it looks like there could be a mix

and more »

This Article Was Originally From *This Site*

Powered by WPeMatico